Literature DB >> 24698799

Genetic deletion of PDE10A selectively impairs incentive salience attribution and decreases medium spiny neuron excitability.

Elisabeth Piccart1, Jean-François De Backer2, David Gall3, Laurie Lambot4, Adam Raes5, Greet Vanhoof6, Serge Schiffmann7, Rudi D'Hooge8.   

Abstract

The striatum is the main input structure to the basal ganglia and consists mainly out of medium spiny neurons. The numerous spines on their dendrites render them capable of integrating cortical glutamatergic inputs with a motivational dopaminergic signal that originates in the midbrain. This integrative function is thought to underly attribution of incentive salience, a process that is severely disrupted in schizophrenic patients. Phosphodiesterase 10A (PDE10A) is located mainly to the striatal medium spiny neurons and hydrolyses cAMP and cGMP, key determinants of MSN signaling. We show here that genetic depletion of PDE10A critically mediates attribution of salience to reward-predicting cues, evident in impaired performance in PDE10A knockout mice in an instrumentally conditioned reinforcement task. We furthermore report modest impairment of latent inhibition in PDE10A knockout mice, and unaltered prepulse inhibition. We suggest that the lack of effect on PPI is due to the pre-attentional nature of this task. Finally, we performed whole-cell patch clamp recordings and confirm suggested changes in intrinsic membrane excitability. A decrease in spontaneous firing in striatal medium spiny neurons was found. These data show that PDE10A plays a pivotal role in striatal signaling and striatum-mediated salience attribution.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Incentive salience; Medium spiny neurons; PDE10A; Schizophrenia; Striatum

Mesh:

Substances:

Year:  2014        PMID: 24698799     DOI: 10.1016/j.bbr.2014.03.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  8 in total

1.  Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination.

Authors:  Zhiwei Xiao; Huiyi Wei; Yi Xu; Ahmed Haider; Junjie Wei; Shiyu Yuan; Jian Rong; Chunyu Zhao; Guocong Li; Weibin Zhang; Huangcan Chen; Yuefeng Li; Lingling Zhang; Jiyun Sun; Shaojuan Zhang; Hai-Bin Luo; Sen Yan; Qijun Cai; Lu Hou; Chao Che; Steven H Liang; Lu Wang
Journal:  Acta Pharm Sin B       Date:  2021-11-17       Impact factor: 14.903

Review 2.  Future Prospects of Positron Emission Tomography-Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders.

Authors:  Young-Don Son; Young-Bo Kim; Jong-Hoon Kim; Jeong-Hee Kim; Dae-Hyuk Kwon; Haigun Lee; Zang-Hee Cho
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-08

Review 3.  Targets for future clinical trials in Huntington's disease: what's in the pipeline?

Authors:  Edward J Wild; Sarah J Tabrizi
Journal:  Mov Disord       Date:  2014-08-25       Impact factor: 10.338

4.  A novel thermoregulatory role for PDE10A in mouse and human adipocytes.

Authors:  Mohammed K Hankir; Mathias Kranz; Thorsten Gnad; Juliane Weiner; Sally Wagner; Winnie Deuther-Conrad; Felix Bronisch; Karen Steinhoff; Julia Luthardt; Nora Klöting; Swen Hesse; John P Seibyl; Osama Sabri; John T Heiker; Matthias Blüher; Alexander Pfeifer; Peter Brust; Wiebke K Fenske
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

5.  Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study.

Authors:  R Bodén; J Persson; A Wall; M Lubberink; L Ekselius; E-M Larsson; G Antoni
Journal:  Transl Psychiatry       Date:  2017-03-07       Impact factor: 6.222

6.  NF1-cAMP signaling dissociates cell type-specific contributions of striatal medium spiny neurons to reward valuation and motor control.

Authors:  Laurie P Sutton; Brian S Muntean; Olga Ostrovskaya; Stefano Zucca; Maria Dao; Cesare Orlandi; Chenghui Song; Keqiang Xie; Kirill A Martemyanov
Journal:  PLoS Biol       Date:  2019-10-10       Impact factor: 8.029

Review 7.  PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action?

Authors:  Frank S Menniti; Thomas A Chappie; Christopher J Schmidt
Journal:  Front Neurosci       Date:  2021-01-20       Impact factor: 4.677

8.  Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats.

Authors:  Bart de Laat; Yvonne E Kling; Gwen Schroyen; Maarten Ooms; Jacob M Hooker; Guy Bormans; Koen Van Laere; Jenny Ceccarini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-17       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.